{"id":8923,"date":"2026-09-09T19:00:23","date_gmt":"2026-09-09T19:00:23","guid":{"rendered":"https:\/\/intelekbusinessvaluations.com\/en-au\/?page_id=8923"},"modified":"2026-09-09T19:00:49","modified_gmt":"2026-09-09T19:00:49","slug":"ma-transaction-valuations","status":"publish","type":"page","link":"https:\/\/intelekbusinessvaluations.com\/en-au\/ma-transaction-valuations\/","title":{"rendered":"M&A Transaction Valuations"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t

Independent Valuation for Buy-Side, Sell-Side and Deal Structuring<\/h4>

Why Independent Valuation Matters in an M&A Transaction<\/h3>

In a compliance valuation, the number has to satisfy a standard. In a transaction, the number has to survive a negotiation \u2014 and then survive the diligence, the financing, the board approval and, eventually, the completion accounts.<\/p>

Most M&A transactions in the Australian private market are priced by reference to an earnings multiple that both sides argue about, applied to an earnings figure that both sides also argue about, adjusted by a working capital and net debt mechanism that the parties frequently do not fully understand until it produces a number at completion. Value leaks at every one of those points, and it leaks toward whichever party has done the better analysis.<\/p>

An independent valuation does three things a deal adviser’s indicative range does not. It gives the board a defensible basis for approving or rejecting a price, which matters where directors owe duties and where minority shareholders or a trustee are involved. It identifies where value actually sits in the target \u2014 and therefore where the diligence effort and the warranty protection should be concentrated. And it establishes a position that can be defended when the other side’s adviser attacks it, rather than a figure that has to be abandoned in the first round of negotiation.<\/p>

The cost asymmetry is stark. Valuation work costs a fraction of a percentage point of a transaction, and the difference between a well-analysed and a poorly analysed earnings normalisation routinely runs to multiples of the fee.<\/p>

InteleK’s accredited valuation specialists provide independent valuation and valuation advisory for M&A transactions \u2014 buy-side and sell-side valuations, earnings normalisation, price mechanism analysis, earn-out design and valuation, and board-facing opinions on price.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t

Book a Free Consultation Call<\/h3>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t

One of InteleK\u00b4s accredited appraisers is available to listen to your story and answer any questions you may have.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t
\r\n \r\n
\r\n \"Andrew\r\n \r\n Andrew Mackson, CFA, ABV\r\n Book Appointment\r\n <\/span>\r\n <\/span>\r\n <\/div>\r\n <\/a>\r\n<\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Purchase\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t

Where Valuation Sits in the Transaction<\/h3>

Sell-Side \u2014 Before You Go to Market<\/h4>

The most valuable point at which to get a valuation is before a price expectation is set, because a vendor who names a number cannot easily raise it.<\/p>

Sell-side valuation work involves establishing a defensible range on evidence, identifying the normalisation adjustments that support the vendor’s earnings position, and \u2014 often more usefully \u2014 identifying the adjustments a buyer will argue for, so the vendor is not encountering them for the first time across the table. Where value depends on a small number of drivers (a customer concentration, a lease, a key person), knowing that before going to market allows it to be addressed or at least anticipated.<\/p>

Buy-Side \u2014 Before You Commit to a Price<\/h4>

Buy-side valuation supports the price you are prepared to pay and, importantly, the price above which you walk.<\/p>

The work overlaps with financial diligence but is not the same thing. Diligence establishes what the historical numbers actually were; valuation establishes what they are worth. A diligence process that confirms the vendor’s EBITDA to the dollar has not answered whether the multiple being paid for it is justified, or whether the earnings are sustainable at that level once the vendor’s personal involvement ends.<\/p>

Board and Governance Support<\/h4>

Where directors must approve a transaction, where a trustee or responsible entity is involved, where there are minority shareholders, or where the counterparty is related, an independent valuation supports the discharge of the relevant duties.<\/p>

This is distinct from an independent expert report under the Corporations Act, which is a licensed activity for prescribed transactions. For a private transaction, a board-facing valuation opinion is the ordinary tool \u2014 and for related party transactions by listed entities or transactions requiring shareholder approval, the licensing and disclosure requirements need to be assessed with counsel before the engagement is scoped.<\/p>

Post-Completion<\/h4>

Transaction valuations do not end at completion. A purchase price allocation is required for financial reporting under AASB 3, the acquired assets feed impairment testing under AASB 136, and the tax cost setting rules apply where the target joins a tax consolidated group. Work done properly at the transaction stage substantially reduces the cost and the risk of all three.<\/p>

Valuation Approaches in a Transaction Context<\/h3>

Capitalisation of Earnings \u2014 The Working Method<\/h4>

Most Australian private company transactions are priced on a multiple of normalised EBITDA, and the two variables carry the argument.<\/p>

The earnings figure.<\/strong> Normalised, maintainable, forward-looking earnings \u2014 not last year’s reported EBITDA. What “maintainable” means is itself negotiable: a business with a strong recent year argues for the recent result; a buyer argues for a weighted average or for the pre-uplift base. The basis needs to be stated and defended.<\/p>

The multiple.<\/strong> Derived from comparable transaction evidence and listed company trading multiples, adjusted for the differences that matter \u2014 size, growth, customer concentration, management depth, industry structure, and the recurring or contracted proportion of revenue. Listed multiples require a discount for the size and liquidity difference between an ASX-listed company and a private business, and transaction multiples require care about what was actually included in the reported enterprise value.<\/p>

Discounted Cash Flow<\/h4>

More defensible than a multiple where earnings are changing materially, where there is a definable forecast horizon, or where the business is capital intensive and the earnings multiple obscures the reinvestment requirement.<\/p>

In a transaction, the DCF’s weakness is that the forecast usually originates with the vendor. Buy-side, the work is stress-testing it \u2014 against historical achievement, market growth, capacity, and the capital required to deliver it. Sell-side, the work is building a forecast that is ambitious but supportable, because a forecast that fails diligence damages credibility on everything else.<\/p>

Market and Transaction Comparables<\/h4>

Genuinely comparable Australian transactions are the strongest evidence available and the hardest to find, because private transaction terms are rarely disclosed and the reported multiples that are available often omit the earn-out, the working capital adjustment or the retained equity.<\/p>

The discipline is in the comparability analysis, not the list. A transaction multiple presented without commentary on why the target is comparable \u2014 and where it differs \u2014 is asserted rather than evidenced, and the other side’s adviser will say so.<\/p>

Sum of the Parts and Asset-Based<\/h4>

Relevant where the target has distinct business units with different characteristics, where surplus assets sit inside the trading entity, or where the earnings do not support a value above net assets. A sum of the parts analysis is also frequently the route to identifying that part of the target is worth more to a different buyer, which affects both the price and the deal structure.<\/p>

Where Value Actually Leaks<\/h3>

Most of the value at stake in a private M&A transaction moves in a handful of places, and they are not always where the negotiation is focused.<\/p>

Earnings Normalisation<\/h4>

The largest single source of movement, and the most contestable:<\/p>

  • Owner remuneration<\/strong> \u2014 Adjusting to a commercial market rate for the role. In an owner-operated business this is frequently the largest adjustment and it multiplies straight through<\/li>
  • Related-party rent<\/strong> \u2014 Where premises are owned by a vendor entity above or below market<\/li>
  • Private expenses<\/strong> \u2014 Vehicles, travel, family members on payroll, personal costs run through the business<\/li>
  • Non-recurring items<\/strong> \u2014 One-off legal, restructuring, insurance recoveries, abnormal gains and losses. Note the asymmetry: vendors reliably identify one-off costs and rarely identify one-off income<\/li>
  • Accounting policy differences<\/strong> \u2014 Revenue recognition, capitalisation of development costs, provisioning practice, lease treatment<\/li>
  • Pro forma adjustments<\/strong> \u2014 Cost savings the vendor asserts are achievable, or the run-rate effect of a recent contract or price increase. Each needs to be evidenced rather than accepted<\/li>
  • Sustainability of the earnings base<\/strong> \u2014 Whether the normalised figure survives the vendor’s departure at all, which is the personal-versus-commercial goodwill question in a transaction setting<\/li><\/ul>

    The Price Mechanism<\/h4>

    Two structures dominate, and they allocate risk differently.<\/p>

    Locked box<\/strong> \u2014 A price fixed by reference to a historical balance sheet date, with the buyer taking the economics from that date. Requires the reference accounts to be reliable and the leakage protections to be drafted properly. Increasingly common, and cleaner where the target’s accounts are robust.<\/p>

    Completion accounts<\/strong> \u2014 Price adjusted after completion by reference to actual net debt and working capital at completion, against a target. Requires a defensible working capital target, which is where disputes concentrate.<\/p>

    The working capital target<\/strong> is the single most under-analysed number in Australian private M&A. It should reflect the normal level of working capital the business requires to operate, derived from an analysis of monthly balances over a sufficient period to capture seasonality and trend. A target set from a single balance date, or from an average that ignores seasonality or a deteriorating trend, hands value to one side by accident. A target set materially below normal levels transfers value to the vendor; above, to the buyer.<\/p>

    Net debt definition<\/strong> is the second: whether items like customer deposits, deferred revenue, accrued employee entitlements, capex commitments, lease liabilities and related-party balances fall in net debt or working capital determines the price, and the drafting frequently does not resolve it.<\/p>

    Earn-Outs<\/h4>

    Common where the parties cannot agree on value or where the vendor’s continued involvement matters.<\/p>

    Design questions with real value consequences: the metric (revenue is manipulable in one direction, EBITDA in another, and both are affected by how the buyer runs the business post-completion), the threshold and cap, the measurement period, the accounting policies to be applied in measuring it, and the protections against buyer conduct that suppresses the metric.<\/p>

    Valuing an earn-out is separate work from designing it.<\/strong> A probability-weighted assessment of the range of outcomes, discounted for time and risk, gives both parties a sense of what the earn-out is actually worth \u2014 which is usually materially less than its headline maximum, and materially more than a sceptical buyer assumes. It is also required for financial reporting: contingent consideration must be recognised at fair value at acquisition under AASB 3 and, if liability-classified, remeasured each reporting date with the movements flowing through profit or loss.<\/p>

    Scrip and Non-Cash Consideration<\/h4>

    Where consideration includes shares in the acquirer, the vendor is accepting an asset whose value needs assessing on the basis actually received \u2014 a minority parcel, typically illiquid if the acquirer is unlisted, and often subject to escrow or transfer restrictions. Treating scrip at its notional issue price overstates what the vendor is getting.<\/p>

    Synergies<\/h4>

    The question of who pays for synergies is a negotiation, but it should be an informed one. Synergies available to any buyer tend to be priced into the market; synergies specific to one acquirer are that acquirer’s value to create, and paying them away entirely eliminates the acquirer’s return on the transaction. Quantifying them separately from the standalone value makes that visible rather than implicit.<\/p>

    Common Failure Points<\/h3>
    • Price expectation set before any analysis<\/strong>, leaving the vendor unable to move upward<\/li>
    • Last year’s EBITDA treated as maintainable earnings<\/strong>, in either direction<\/li>
    • Multiple asserted from a market impression<\/strong> rather than derived from identified comparable evidence<\/li>
    • Listed multiples applied to a private business<\/strong> without adjustment for size and liquidity<\/li>
    • One-off costs identified, one-off income not<\/strong> \u2014 the most reliable asymmetry in vendor-prepared normalisations<\/li>
    • Pro forma adjustments accepted without evidence<\/strong> of achievability<\/li>
    • Working capital target set from a single balance date<\/strong>, ignoring seasonality and trend<\/li>
    • Net debt definition left ambiguous<\/strong>, producing a completion accounts dispute<\/li>
    • Earn-out designed but never valued<\/strong>, so neither party knows what has actually been agreed<\/li>
    • Earn-out metric vulnerable to post-completion buyer conduct<\/strong>, with no protections<\/li>
    • Scrip taken at issue price<\/strong>, overstating vendor consideration<\/li>
    • Diligence confirming the numbers without anyone asking whether the earnings survive the vendor’s exit<\/strong><\/li>
    • Post-completion accounting not considered<\/strong> until the auditor asks for a purchase price allocation<\/li><\/ul>

      InteleK’s Approach to Transaction Valuations<\/h3>

      Our accredited valuers provide independent valuation for transactions, distinct from and complementary to the work of your corporate adviser. Here’s what sets our process apart:<\/p>

      Independent of the Deal<\/strong> \u2014 We are not paid on completion and have no interest in the transaction proceeding. Where our analysis does not support the price, we say so \u2014 which is the only circumstance in which an independent valuation has any value to a board.<\/p>

      Normalisation Analysed From Both Sides<\/strong> \u2014 Sell-side, we identify the adjustments that support your position and the adjustments the buyer will argue for, before you meet them. Buy-side, we test the vendor’s normalisations against evidence rather than accepting the schedule as presented.<\/p>

      Multiples Derived, Not Asserted<\/strong> \u2014 From identified comparable transactions and listed peers, with the comparability of each explained and the adjustments for size, growth, concentration and management depth set out. A multiple that cannot be traced to evidence will not hold in a negotiation.<\/p>

      Price Mechanism Analysis<\/strong> \u2014 Working capital targets derived from monthly balance analysis over a period sufficient to capture seasonality and trend, and net debt definition tested item by item for the ambiguities that become completion accounts disputes.<\/p>

      Earn-Outs Designed and Valued<\/strong> \u2014 Probability-weighted valuation of the range of outcomes so both parties know what has been agreed, alongside advice on metric selection and the protections that stop the metric being suppressed post-completion.<\/p>

      Sustainability of Earnings Assessed<\/strong> \u2014 Whether the normalised earnings survive the vendor’s departure, which is the question diligence most often confirms the numbers without answering.<\/p>

      Board-Facing Deliverables<\/strong> \u2014 Where directors, a trustee or minority shareholders need a basis for approving a price, a valuation report structured for that purpose, with the range, the sensitivities and the basis clearly stated.<\/p>

      Post-Completion Continuity<\/strong> \u2014 The same analysis feeds the AASB 3 purchase price allocation, the AASB 136 impairment testing baseline and the tax cost setting work. Doing it once properly is materially cheaper than doing it twice.<\/p>

      Working With Your Advisers<\/strong> \u2014 We work alongside your corporate adviser, transaction counsel, tax adviser and diligence team. The valuation informs the negotiation; it does not replace the adviser running it.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

      \n\t\t\t\t\t\t
      \n\t\t\t\t\t
      \n\t\t\t
      \n\t\t\t\t\t\t\t\t
      \n\t\t\t\t
      \n\t\t\t
      \r\n